Darglitazone
Alternative Names: CP 86325-2Latest Information Update: 08 Nov 1999
At a glance
- Originator Pfizer
- Class Antihyperglycaemics; Small molecules; Thiazolidinediones
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus